A study makes it possible to calculate for the first time the cardiovascular risk in people with diabetes 2
It is the result of the SCORE2-Diabetes project developed in four European regions, with the participation of IDIAPJGol and CIBERDEM. Its implementation will make it possible to prevent, diagnose complications early and start treatments that reduce the risk of cardiovascular problems among the more than 5 million people affected by this disease in Spain.
Reliably predicting the cardiovascular risk of people with type 2 diabetes is already a reality, thanks to the ""SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe”" study, which has analyzed almost 239,000 people and more of 43,000 cardiovascular events from four regions of Europe, the study was promoted by the SCORE2 Working Group, in which researchers from the DAP-cat Research Group of the Jordi Gol Institute for Primary Health Care Research (IDIAPJGol) and from the Network Biomedical Research Center focused on Diabetes and Associated Metabolic Diseases (CIBERDEM).
Type 2 diabetes affects more than 5 million people in Spain. Because they suffer from the disease, they are at greater risk of suffering cardiovascular problems than the general population, and these are more severe and evolve more quickly. This has a very high impact in terms of quality loss and years of life.
The results of this research will make it possible to adopt preventive measures, diagnose complications early and initiate treatments that reduce the risk of suffering cardiovascular problems among people with type 2 diabetes. The European Society of Cardiology, as a result of the SCORE project, has developed a application ((ESC CVD Risk Calculation)) designed for healthcare professionals that provides calculators that assess individual cardiovascular risk, now also specifically in people with type 2 diabetes.
The DAP-cat coordinator, Josep Franch Nadal, explains that the study has detected important differences between regions: "We, as the Mediterranean population, form part of the stratum of very low cardiovascular risk." To carry out the study, SIDIAP, the IDIAPJGol research database that collects information on clinical practice in Primary Care in Catalonia, has been used: "The data have served us to calibrate and verify the results in our population and in other countries with a level of risk similar to ours”, explains this researcher at the USR Barcelona of the IDIAPJGol and doctor of the Primary Care of Barcelona of the Catalan Institute of Health.
